Because lipid accumulation, lipotoxicity, oxidative stress, and ER stress all appear to be fundamental drivers of NASH pathogenesis, FGF21-based therapies may be broadly useful in a potentially heterogeneous NASH patient population
Despite showing an increase in SIBO likelihood, the numbers were minimal (fewer than 0.02%), and the study did not prove causation, only a correlation based on a yes/no diagnosis
Meanwhile, macronutrient tracking and Success Kit updates include a protein tracker and a high protein tag for foods with a high protein-to-calorie ratio
Heres a detailed look at what to know about dosages, timing, and monitoring for safe and effective use of these medications
The plan: create 40 dramas in 18 months
Valvular heart disease